Whanin Pharm Co (XKRX:016580) 3-Year EBITDA Growth Rate : 4.80% (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co 3-Year EBITDA Growth Rate?

Whanin Pharm Co's EBITDA per Share for the three months ended in Mar. 2024 was ₩849.48.

During the past 12 months, Whanin Pharm Co's average EBITDA Per Share Growth Rate was 28.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 4.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 5.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Whanin Pharm Co was 11.40% per year. The lowest was -2.90% per year. And the median was 5.55% per year.

Competitive Comparison of Whanin Pharm Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Whanin Pharm Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Whanin Pharm Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Whanin Pharm Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Whanin Pharm Co's 3-Year EBITDA Growth Rate falls into.

Whanin Pharm Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Whanin Pharm Co (XKRX:016580) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Whanin Pharm Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Whanin Pharm Co (XKRX:016580) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200

Website

http://www.whanin.co.kr

Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co (XKRX:016580) Headlines

No Headlines